Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (141-150 of 287) with videos related to

Pageof 29
Sort By:
Current Cardiology Reports|January 26, 2026
Race and Patient-Physician Communication on Blood Pressure Management: Helping Improve CareSamar A Nasser, Ashley Pender, Ayan Ali, et al.
Cardiovascular Diagnosis and Therapy|July 14, 2025
Association between the cardiometabolic index and all-cause and cardiovascular mortality in diabetes and prediabetesYing Wang, Keith C Ferdinand, Carmine Gazzaruso, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
A systematic review of racial/ethnic disparities in pharmacotherapy and surgical treatment outcomes in peripheral arterial disease among African American/non-Hispanic Black, non-Hispanic White and Hispanic patientsSaihariharan Nedunchezhian, Tina K Reddy, Madeline Wegener, et al.
Postgraduate Medicine|October 31, 2002
Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcomeJames R Sowers, Keith C Ferdinand, George L Bakris, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) studyRichard F Wright, Daniel Duprez, Das Purkayastha, et al.
Cardiology Clinics|October 13, 2010
Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populationsJohn M Flack, Keith C Ferdinand, Samar A Nasser, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 10, 2015
Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-AnalysisBertrand N Mukete, Mark Cassidy, Keith C Ferdinand, et al.
Circulation Research|March 13, 2025
Sex-Specific Factors Influencing Obesity in Women: Bridging the Gap Between Science and Clinical PracticeHazem Ayesh, Samar A Nasser, Keith C Ferdinand, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic ReviewKeith C Ferdinand, Keith C Norris, Helena W Rodbard, et al.
Cardiovascular Diabetology|February 26, 2016
Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular eventsKeith C Ferdinand, Fady T Botros, Charles M Atisso, et al.
Pageof 29

Showing results (141-150 of 287) with videos related to

Sort By:
Pageof 29
Current Cardiology Reports|January 26, 2026
Race and Patient-Physician Communication on Blood Pressure Management: Helping Improve CareSamar A Nasser, Ashley Pender, Ayan Ali, et al.
Cardiovascular Diagnosis and Therapy|July 14, 2025
Association between the cardiometabolic index and all-cause and cardiovascular mortality in diabetes and prediabetesYing Wang, Keith C Ferdinand, Carmine Gazzaruso, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
A systematic review of racial/ethnic disparities in pharmacotherapy and surgical treatment outcomes in peripheral arterial disease among African American/non-Hispanic Black, non-Hispanic White and Hispanic patientsSaihariharan Nedunchezhian, Tina K Reddy, Madeline Wegener, et al.
Postgraduate Medicine|October 31, 2002
Hypertension-related disease in African Americans. Factors underlying disparities in illness and its outcomeJames R Sowers, Keith C Ferdinand, George L Bakris, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 3, 2011
Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension: the exforge as compared to losartan treatment in stage 2 systolic hypertension (EXALT) studyRichard F Wright, Daniel Duprez, Das Purkayastha, et al.
Cardiology Clinics|October 13, 2010
Hypertension in special populations: chronic kidney disease, organ transplant recipients, pregnancy, autonomic dysfunction, racial and ethnic populationsJohn M Flack, Keith C Ferdinand, Samar A Nasser, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 10, 2015
Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-AnalysisBertrand N Mukete, Mark Cassidy, Keith C Ferdinand, et al.
Circulation Research|March 13, 2025
Sex-Specific Factors Influencing Obesity in Women: Bridging the Gap Between Science and Clinical PracticeHazem Ayesh, Samar A Nasser, Keith C Ferdinand, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic ReviewKeith C Ferdinand, Keith C Norris, Helena W Rodbard, et al.
Cardiovascular Diabetology|February 26, 2016
Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular eventsKeith C Ferdinand, Fady T Botros, Charles M Atisso, et al.
Pageof 29